How to achieve industry compliance within a highly regulated setting
Discover how a large UK pharmaceuticals manufacturer improved its data quality and real time reporting capabilities, as well as remaining compliant within a highly regulated industry
Pharmaceutical Manufacturing:
Enterprise Asset Management Within a Highly Regulated Industry
(This event has past - Tues Jan 26, 2021, 2:00 PM GMT)
You can still watch the webinar by clicking here
![BPDZenith_logo_poweredby BPDZenith_logo_poweredby](https://offers.bpdzenith.com/hubfs/BPDZenith_logo_poweredby.png)
![iStock-907835356 iStock-907835356](https://offers.bpdzenith.com/hubfs/Pharma%20UK/iStock-907835356.jpg)
![iStock-476406659 iStock-476406659](https://offers.bpdzenith.com/hs-fs/hubfs/Pharma%20UK/iStock-476406659.jpg?width=3864&height=2576&name=iStock-476406659.jpg)
![iStock-899692866 iStock-899692866](https://offers.bpdzenith.com/hs-fs/hubfs/Pharma%20UK/iStock-899692866.jpg?width=3864&height=2174&name=iStock-899692866.jpg)
BPD Zenith - Explore some of the industry challenges faced by a large UK pharmaceuticals manufacturer in choosing to upgrade their IBM Maximo EAM solution. This included functionality for mobility, calibration and enhanced reporting - all within a strictly regulated and certified industry. Find out how this led to a reduction of 40% in unplanned work in just 6 months!
We explore the importance of data quality from its input source, through to live enhanced reporting, and how this was implemented as part of a business-critical upgrade.
Join BPD Zenith to discover:-
Modern EAM System Benefits
-
Creating an Optimised Mobile Workforce
-
Calibration
-
Business Intelligence Reporting
-
40% Reduction of Unplanned Work in just 6 months!
-
Delivered on time and within budget
More from BPD about the project...
![A Complete Life Sciences Solution Employ a single-vendor solution that offers a risk-based approach for asset management to address Food and Drug Administration (FDA) regulations, including Good Manufacturing Practices (GMP) and FDA 21 CFR Part 11 A Complete Life Sciences Solution Employ a single-vendor solution that offers a risk-based approach for asset management to address Food and Drug Administration (FDA) regulations, including Good Manufacturing Practices (GMP) and FDA 21 CFR Part 11](https://offers.bpdzenith.com/hubfs/iStock-1150397417.jpg)
Asset Management for Life Sciences
This paper outlines important strategic considerations for implementing asset
management in life sciences organizations. It also describes the IBM Maximo®
asset management solution for the life sciences industry
![iStock-1206802147 iStock-1206802147](https://offers.bpdzenith.com/hubfs/Pharma%20UK/iStock-1206802147.jpg)
A Complete Life Sciences Solution
Employ a single-vendor solution that offers a risk-based approach for asset management to address Food and Drug Administration (FDA) regulations, including Good Manufacturing Practices (GMP) and FDA 21 CFR Part 11